Rare diseases
Investigational molecules
Locations
A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
PortugalA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
PortugalA study of navenibart for long-term safety in patients with hereditary angioedema
PortugalStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PortugalA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
PortugalStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
PortugalStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
PortugalStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
PortugalStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
PortugalStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
PortugalStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
PortugalStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients
PortugalTell us about your condition – we search every trial in Europe and connect you with the right site.
